SynerFuse™ Announces Issuance of Key U.S. Patent on N

SynerFuse™ Announces Issuance of Key U.S. Patent on Novel Use of Neuromodulation for Treatment of Chronic Back Pain

/PRNewswire/ -- SynerFuse, Inc., a privately held, clinical-stage medical device company focused on the development of a novel neuromodulation therapy concept...

Related Keywords

, Synerfuse Inc , Us Patent Trademark Office , Trademark Office , Neuromodulation System , Surgically Open Spinal Treatment , Spinal Fixation System , Surgically Open Spinal Treatment Site , Synerfuse ,